Back
EHRA Premium Access

Comparison of risk-stratification algorithms to predict outcome and clinical response in patients with cardiac resynchronization therapy

Session: Poster session 3 - Cardiac Resynchronization Therapy
Topic: Cardiac Resynchronisation Therapy (CRT)
Speaker: Doctor G. Arena (Massa, IT)
Event: EHRA 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Giuseppe Arena

Apuane General Hospital, Massa (Italy)
0 follower

26 more presentations in this session

Statistical ranking of electromechanical dyssynchrony parameters for cardiac resynchronisation therapy

Speaker: Doctor S. Cazeau (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

Left ventricular scar predicts remodeling in patients undergoing cardiac resynchronisation therapy - A retrospective analysis from a large tertiary centre

Speaker: Ms K. Thomasson (Greater London, GB)

Access
Abstract
Slides
Like
Thumbnail

Lead positioning for cardiac resynchronization therapy, a randomized trial comparing an active fixation bipolar left ventricular lead and a passive fixation quadripolar lead

Speaker: Mr H. Keilegavlen (Bergen, NO)

Access
Abstract
Slides
Like
Thumbnail

Clinical outcome of cardiac resynchronization therapy in patients randomized to an active fixation bipolar left ventricular lead versus a passive quadripolar lead

Speaker: Mr H. Keilegavlen (Bergen, NO)

Access
Abstract
Slides
Like
Thumbnail

Benefit of primary prophylactic ICD-therapy in nonischemic compared to ischemic cardiomyopathy with and without cardiac resynchronization therapy

Speaker: Doctor T. Kleemann (Ludwigshafen, DE)

Access
Abstract
Like
Thumbnail

Access the full session

Poster session 3 - Cardiac Resynchronization Therapy

Speakers: Doctor G. Arena, Doctor S. Cazeau, Ms K. Thomasson, Mr H. Keilegavlen, Mr H. Keilegavlen...
Access
Like
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources